ApplicationThis product is optimized to assess platform characteristics, including:
Repeatability/Reproducibility between runs
System stability (drift, chromatography, signal intensity, sensitivity, etc.)
Inter- and intra- platform and lab comparisons
To view a poster by Tobias Kockmann and colleagues at ETH Zurich on the use of MSQC1 in multiple LC-MS platforms, please visit this poster link.
Features and BenefitsGeneralComplexity
Defined mixture gives confidence in your instruments analysis
QualitativeMixture of 6 tryptically digested human proteins (FASTA file)
Low complexity, defined mixture
25 fold concentration range
C18 purified
14 SIL peptides
SIL peptides span a concentration range greater than three orders of magnitude (Table 1)
2 - 3 peptides per protein
QuantitativeMRM settings provided (xls)
MRM transitions provided (file above)
Light : Heavy ratios from 50:1 to 1:5
Analysis NoteUp to 100 uses based upon the recommended reconstitution method
Other NotesEach vial contains 6 pre-digested (trypsin) human proteins plus 14 corresponding stable isotope labeled (SIL) peptides (7-8 μg total dried in a 0.5 mL vial).
Legal InformationThis product is licensed under U.S. Patent No. 7,396,688 and foreign counterparts from E. I. du Pont de Nemours and Company. The purchase of this product conveys to the buyer the nontransferable right to use the purchased amount of the product for research and development only, including services for a third party for consideration. The buyer cannot sell or otherwise transfer this product, its components or materials made using this product or its components to a third party. Information about licenses for excluded uses is available from: E. I. du Pont de Nemours and Company; Attn: Associate Director, Commercial Development; DuPont Experimental Station E268; 200 Powdermill Rd.; Wilmington, DE 19803; 1-877-881-9787 (voice), 1-302-695-1437 (fax),
[email protected].
